Anagenics Limited (AU:AN1)
ASX:AN1
Australian Market
Holding AU:AN1?
Track your performance easily

Anagenics Limited (AN1) Share Price & Analysis

0 Followers

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.00%98.00%
― Other Institutional Investors
98.00% Public Companies and
Individual Investors

AN1 FAQ

What was Anagenics Limited’s price range in the past 12 months?
Currently, no data Available
What is Anagenics Limited’s market cap?
Currently, no data Available
When is Anagenics Limited’s upcoming earnings report date?
Anagenics Limited’s upcoming earnings report date is Feb 26, 2025 which is in 108 days.
    How were Anagenics Limited’s earnings last quarter?
    Anagenics Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.014.
      Is Anagenics Limited overvalued?
      According to Wall Street analysts Anagenics Limited’s price is currently same. Get more investment ideas with TipRanks Premium
        Does Anagenics Limited pay dividends?
        Anagenics Limited does not currently pay dividends.
        What is Anagenics Limited’s EPS estimate?
        Anagenics Limited’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Anagenics Limited have?
        Anagenics Limited has 461,320,370 shares outstanding.
          What happened to Anagenics Limited’s price movement after its last earnings report?
          Anagenics Limited reported an EPS of -AU$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
            Which hedge fund is a major shareholder of Anagenics Limited?
            Currently, no hedge funds are holding shares in AU:AN1
            ---

            Anagenics Limited Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            -125.53%
            Trailing 12-Months
            Asset Growth
            -44.28%
            Trailing 12-Months

            Company Description

            Anagenics Limited

            Cellmid Ltd develops and sells diagnostic and therapeutic products for diseases such as cancer and chronic inflammatory conditions. Its principal activities are divided into Midkine Business and Consumer Health Business. The group is organized into two operating segments: Research and development of diagnostics and therapeutics; and Research, development, and marketing of hair growth products. The company derives most of its revenue from Consumer Health. It derives most of its geographical revenue from Japan.
            ---
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis